BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2558314)

  • 1. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).
    Dubinsky RM; Yarchoan R; Dalakas M; Broder S
    Muscle Nerve; 1989 Oct; 12(10):856-60. PubMed ID: 2558314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
    Skowron G; Bozzette SA; Lim L; Pettinelli CB; Schaumburg HH; Arezzo J; Fischl MA; Powderly WG; Gocke DJ; Richman DD; Pottage JC; Antoniskis D; McKinley GF; Hyslop NE; Ray G; Simon G; Reed N; LoFaro ML; Uttamchandani RB; Gelb LD; Sperber SJ; Murphy RL; Leedom JM; Grieco MH; Zachary J; Hirsch MS; Spector SA; Bigley J; Soo W; Merigan TC
    Ann Intern Med; 1993 Mar; 118(5):321-30. PubMed ID: 8094279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients.
    Berger AR; Arezzo JC; Schaumburg HH; Skowron G; Merigan T; Bozzette S; Richman D; Soo W
    Neurology; 1993 Feb; 43(2):358-62. PubMed ID: 8382349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).
    Yarchoan R; Perno CF; Thomas RV; Klecker RW; Allain JP; Wills RJ; McAtee N; Fischl MA; Dubinsky R; McNeely MC
    Lancet; 1988 Jan; 1(8577):76-81. PubMed ID: 2891981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternating and intermittent regimens of zidovudine (3'-azido-3'-deoxythymidine) and dideoxycytidine (2',3'-dideoxycytidine) in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
    Skowron G; Merigan TC
    Am J Med; 1990 May; 88(5B):20S-23S. PubMed ID: 2159705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Arceo R; Brosnan C; Arezzo J; Schaumburg H
    Lab Invest; 1992 Jan; 66(1):63-74. PubMed ID: 1309930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study.
    Merigan TC; Skowron G; Bozzette SA; Richman D; Uttamchandani R; Fischl M; Schooley R; Hirsch M; Soo W; Pettinelli C
    Ann Intern Med; 1989 Feb; 110(3):189-94. PubMed ID: 2536257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC).
    Dalakas MC; Semino-Mora C; Leon-Monzon M
    Lab Invest; 2001 Nov; 81(11):1537-44. PubMed ID: 11706061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat.
    Chen X; Levine JD
    Mol Pain; 2007 Feb; 3():5. PubMed ID: 17319957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New, in Austria registered specialty drugs. Hivid (2',3'-dideoxycytidine; ddC)].
    Töglhofer W
    Wien Klin Wochenschr; 1992; 104(12):363-7. PubMed ID: 1353278
    [No Abstract]   [Full Text] [Related]  

  • 11. AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
    Meng TC; Fischl MA; Richman DD
    Am J Med; 1990 May; 88(5B):27S-30S. PubMed ID: 2159707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.
    Pizzo PA; Butler K; Balis F; Brouwers E; Hawkins M; Eddy J; Einloth M; Falloon J; Husson R; Jarosinski P
    J Pediatr; 1990 Nov; 117(5):799-808. PubMed ID: 2172501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructure of peripheral neuropathy induced in rabbits by 2',3'-dideoxycytidine.
    Feldman D; Brosnan C; Anderson TD
    Lab Invest; 1992 Jan; 66(1):75-85. PubMed ID: 1309931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Merigan TC; Skowron G
    Am J Med; 1990 May; 88(5B):11S-15S. PubMed ID: 2159703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RNA-binding protein HuD promotes spinal GAP43 overexpression in antiretroviral-induced neuropathy.
    Sanna MD; Quattrone A; Mello T; Ghelardini C; Galeotti N
    Exp Neurol; 2014 Nov; 261():343-53. PubMed ID: 24861443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-human immunodeficiency virus type 1 therapy and peripheral neuropathy: prevention of 2',3'-dideoxycytidine toxicity in PC12 cells, a neuronal model, by uridine and pyruvate.
    Keilbaugh SA; Hobbs GA; Simpson MV
    Mol Pharmacol; 1993 Oct; 44(4):702-6. PubMed ID: 8232219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine.
    Kieburtz KD; Seidlin M; Lambert JS; Dolin R; Reichman R; Valentine F
    J Acquir Immune Defic Syndr (1988); 1992; 5(1):60-4. PubMed ID: 1346633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of the bioavailability and pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS or AIDS-related complex.
    Gustavson LE; Fukuda EK; Rubio FA; Dunton AW
    J Acquir Immune Defic Syndr (1988); 1990; 3(1):28-31. PubMed ID: 2152803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms.
    Ferrari LF; Levine JD
    Eur J Neurosci; 2010 Sep; 32(5):811-8. PubMed ID: 20726883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.